Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Pharmacotherapy|July 30, 2003
Coadministration of milk thistle and indinavir in healthy subjectsRobert DiCenzo, Mark Shelton, Kelly Jordan, et al.American Journal of Pharmaceutical Education|March 5, 2016
Deliberate Integration of Student Leadership Development in Doctor of Pharmacy ProgramsKristin K Janke, Michael H Nelson, Andrew S Bzowyckyj, et al.Antimicrobial Agents and Chemotherapy|February 26, 2004
Pharmacokinetics of indinavir and nelfinavir in treatment-naive, human immunodeficiency virus-infected subjectsRobert DiCenzo, Alan Forrest, Margaret A Fischl, et al.Antimicrobial Agents and Chemotherapy|June 25, 2008
Effects of minocycline and valproic acid coadministration on atazanavir plasma concentrations in human immunodeficiency virus-infected adults receiving atazanavir-ritonavirRobert DiCenzo, Derick R Peterson, Kim Cruttenden, et al.Clinical Pharmacokinetics|March 1, 2008
Antiretroviral therapy : pharmacokinetic considerations in patients with renal or hepatic impairmentSarah M McCabe, Qing Ma, Judianne C Slish, et al.Journal of Pharmaceutical and Biomedical Analysis|July 3, 2007
Determination of lopinavir cerebral spinal fluid and plasma ultrafiltrate concentrations by liquid chromatography coupled to tandem mass spectrometryRobin DiFrancesco, Robert DiCenzo, Glorimar Vicente, et al.Antimicrobial Agents and Chemotherapy|May 23, 2003
Indinavir, efavirenz, and abacavir pharmacokinetics in human immunodeficiency virus-infected subjectsRobert DiCenzo, Alan Forrest, Kathleen E Squires, et al.Journal of Clinical Toxicology|April 29, 2014
Monocarboxylate Transporter Inhibition with Osmotic Diuresis Increases γ-Hydroxybutyrate Renal Elimination in Humans: A Proof-of-Concept StudyMarilyn E Morris, Bridget L Morse, Gloria J Baciewicz, et al.Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Pharmacokinetic drug interactions with non-nucleoside reverse transcriptase inhibitorsQing Ma, Olanrewaju O Okusanya, Patrick F Smith, et al.Clinical Pharmacokinetics|January 7, 2005
Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individualsPatrick F Smith, Robert Dicenzo, Alan Forrest, et al.Pageof 3